S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

Fulgent Genetics (FLGT) SEC Filings & 10K Form

$20.09
-0.63 (-3.04%)
(As of 04/17/2024 ET)

Recent Fulgent Genetics SEC Filings

DateFilerForm TypeView
03/12/2024
6:07 PM
Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
Ming Hsieh Trust (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:26 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:27 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:28 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:10 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:11 PM
Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:11 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:12 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:08 AM
Fulgent Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
5:50 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:52 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:55 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:48 PM
Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
6:27 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
6:26 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:01 PM
Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
3:39 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:21 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:21 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:21 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
7:49 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
8:43 PM
Fulgent Genetics (Subject)
Xie Jian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2023
5:00 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
4:47 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
4:54 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
5:12 PM
Fulgent Genetics (Subject)
Gao Hanlin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2023
5:12 PM
Fulgent Genetics (Subject)
Kim Paul (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2023
5:13 PM
Fulgent Genetics (Subject)
Xie Jian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2023
3:27 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
3:30 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
8:21 PM
Fulgent Genetics (Subject)
Kim Paul (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/16/2023
8:21 PM
Fulgent Genetics (Subject)
Xie Jian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/03/2023
3:54 PM
Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
6:31 AM
Fulgent Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/03/2023
6:09 AM
Fulgent Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2023
4:38 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2023
4:24 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2023
4:25 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2023
4:27 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
3:34 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
3:35 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!
09/11/2023
3:37 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2023
5:59 PM
Fulgent Genetics (Subject)
Kim Paul (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
6:00 PM
Fulgent Genetics (Subject)
Xie Jian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2023
5:09 PM
Fulgent Genetics (Subject)
Kim Paul (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2023
4:33 PM
Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
Ming Hsieh Trust (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2023
3:40 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2023
3:43 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2023
3:34 PM
Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
3:51 PM
Fulgent Genetics (Subject)
Kim Paul (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2023
3:51 PM
Fulgent Genetics (Subject)
Xie Jian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2023
3:54 PM
Fulgent Genetics (Subject)
Gao Hanlin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2023
4:34 PM
Fulgent Genetics (Issuer)
Kim Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2023
4:38 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2023
6:14 AM
Fulgent Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/04/2023
6:07 AM
Fulgent Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
4:26 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
4:11 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
5:02 AM
Fulgent Genetics (Subject)
Xie Jian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/02/2023
5:03 AM
Fulgent Genetics (Subject)
Kim Paul (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/02/2023
5:08 AM
Fulgent Genetics (Subject)
Gao Hanlin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/22/2023
3:45 PM
Fulgent Genetics (Issuer)
Nohaile Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
3:55 PM
Fulgent Genetics (Issuer)
GROVES REGINA E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
3:38 PM
Fulgent Genetics (Issuer)
Marsh Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2023
3:42 PM
Fulgent Genetics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/05/2023
6:05 AM
Fulgent Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2023
6:24 AM
Fulgent Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2023
4:28 PM
Fulgent Genetics (Issuer)
Xie Jian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:FLGT) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners